Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 60

1.

Establishment of digital cutoff values for intraepithelial lymphocytes in biopsies from colonic mucosa with lymphocytic colitis.

Fiehn AK, Clausen LN, Engel U, Munck LK, Kristensson M, Engel PJH.

Pathol Res Pract. 2019 Aug 8:152580. doi: 10.1016/j.prp.2019.152580. [Epub ahead of print]

PMID:
31522788
2.

Is revision of cutoff values needed when using CD3 immunohistochemical staining in histopathologic diagnosis of lymphocytic colitis?

Fiehn AK, Clausen LN, Engel U, Wildt S, Munck LK, Kristensson M, Engel PJH.

Hum Pathol. 2019 Feb;84:115-123. doi: 10.1016/j.humpath.2018.08.031. Epub 2018 Sep 18.

PMID:
30240770
3.

Clinical features of sarcoidosis associated pulmonary hypertension: Results of a multi-national registry.

Baughman RP, Shlobin OA, Wells AU, Alhamad EH, Culver DA, Barney J, Cordova FC, Carmona EM, Scholand MB, Wijsenbeek M, Ganesh S, Birring SS, Kouranos V, O'Hare L, Baran JM, Cal JG, Lower EE, Engel PJ, Nathan SD.

Respir Med. 2018 Jun;139:72-78. doi: 10.1016/j.rmed.2018.04.015. Epub 2018 May 5.

PMID:
29858005
4.

Microscopic colitis in Denmark and Sweden: incidence, putative risk factors, histological assessment and endoscopic activity.

Davidson S, Sjöberg K, Engel PJH, Lo Rinc E, Fiehn AK, Vigren L, Munck LK.

Scand J Gastroenterol. 2018 Jun - Jul;53(7):818-824. doi: 10.1080/00365521.2018.1476583. Epub 2018 May 31.

PMID:
29852792
5.

The subtypes of microscopic colitis from a pathologist's perspective: past, present and future.

Engel PJH, Fiehn AK, Munck LK, Kristensson M.

Ann Transl Med. 2018 Feb;6(3):69. doi: 10.21037/atm.2017.03.16.

6.

Automated image analysis in the study of collagenous colitis.

Fiehn AM, Kristensson M, Engel U, Munck LK, Holck S, Engel PJ.

Clin Exp Gastroenterol. 2016 Apr 8;9:89-95. doi: 10.2147/CEG.S101219. eCollection 2016.

7.

CD3 immunohistochemical staining in diagnosis of lymphocytic colitis.

Fiehn AM, Engel U, Holck S, Munck LK, Engel PJ.

Hum Pathol. 2016 Feb;48:25-31. doi: 10.1016/j.humpath.2015.09.037. Epub 2015 Oct 29.

PMID:
26772395
8.

Selexipag for the Treatment of Pulmonary Arterial Hypertension.

Sitbon O, Channick R, Chin KM, Frey A, Gaine S, Galiè N, Ghofrani HA, Hoeper MM, Lang IM, Preiss R, Rubin LJ, Di Scala L, Tapson V, Adzerikho I, Liu J, Moiseeva O, Zeng X, Simonneau G, McLaughlin VV; GRIPHON Investigators.

N Engl J Med. 2015 Dec 24;373(26):2522-33. doi: 10.1056/NEJMoa1503184.

9.

Pulmonary Hypertension in Sarcoidosis.

Baughman RP, Engel PJ, Nathan S.

Clin Chest Med. 2015 Dec;36(4):703-14. doi: 10.1016/j.ccm.2015.08.011. Epub 2015 Oct 9. Review.

PMID:
26593143
10.

The Temporal Evolution of Histological Abnormalities in Microscopic Colitis.

Rasmussen J, Engel PJ, Wildt S, Fiehn AM, Munck LK.

J Crohns Colitis. 2016 Mar;10(3):262-8. doi: 10.1093/ecco-jcc/jjv200. Epub 2015 Oct 31.

11.

Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension.

Galiè N, Barberà JA, Frost AE, Ghofrani HA, Hoeper MM, McLaughlin VV, Peacock AJ, Simonneau G, Vachiery JL, Grünig E, Oudiz RJ, Vonk-Noordegraaf A, White RJ, Blair C, Gillies H, Miller KL, Harris JH, Langley J, Rubin LJ; AMBITION Investigators.

N Engl J Med. 2015 Aug 27;373(9):834-44. doi: 10.1056/NEJMoa1413687.

12.

[The Danish introductory position provides a qualified choice of specialty].

Lillevang G, Mikines KJ, Ostergaard HT, Engel PJ.

Ugeskr Laeger. 2014 Feb 24;176(9A):V09130573. Danish.

PMID:
25350411
13.

Bosentan for sarcoidosis-associated pulmonary hypertension: a double-blind placebo controlled randomized trial.

Baughman RP, Culver DA, Cordova FC, Padilla M, Gibson KF, Lower EE, Engel PJ.

Chest. 2014 Apr;145(4):810-817. doi: 10.1378/chest.13-1766.

PMID:
24177203
14.

Observer variability in the histopathologic diagnosis of microscopic colitis and subgroups.

Fiehn AM, Bjørnbak C, Warnecke M, Engel PJ, Munck LK.

Hum Pathol. 2013 Nov;44(11):2461-6. doi: 10.1016/j.humpath.2013.06.004. Epub 2013 Sep 9.

PMID:
24029708
15.

Macitentan and morbidity and mortality in pulmonary arterial hypertension.

Pulido T, Adzerikho I, Channick RN, Delcroix M, Galiè N, Ghofrani HA, Jansa P, Jing ZC, Le Brun FO, Mehta S, Mittelholzer CM, Perchenet L, Sastry BK, Sitbon O, Souza R, Torbicki A, Zeng X, Rubin LJ, Simonneau G; SERAPHIN Investigators.

N Engl J Med. 2013 Aug 29;369(9):809-18. doi: 10.1056/NEJMoa1213917.

16.

Microscopic colitis: clinical findings, topography and persistence of histopathological subgroups.

Bjørnbak C, Engel PJ, Nielsen PL, Munck LK.

Aliment Pharmacol Ther. 2011 Nov;34(10):1225-34. doi: 10.1111/j.1365-2036.2011.04865.x. Epub 2011 Oct 3.

17.

Inhaled iloprost for sarcoidosis associated pulmonary hypertension.

Baughman RP, Judson MA, Lower EE, Highland K, Kwon S, Craft N, Engel PJ.

Sarcoidosis Vasc Diffuse Lung Dis. 2009 Jul;26(2):110-20.

PMID:
20560291
18.

[What is the pedagogical development function of Region East, Denmark used for?].

Engel PJ, Sørensen HA, Thode J; Postgraduate kliniske lektorer og Sekretariatet for Laegelig Videreuddannelse Øst.

Ugeskr Laeger. 2010 May 31;172(22):1683-5. Danish.

PMID:
20525468
19.

Survival in sarcoidosis-associated pulmonary hypertension: the importance of hemodynamic evaluation.

Baughman RP, Engel PJ, Taylor L, Lower EE.

Chest. 2010 Nov;138(5):1078-85. doi: 10.1378/chest.09-2002. Epub 2010 Mar 26.

PMID:
20348196
20.

Treatment of right ventricular dysfunction in pulmonary arterial hypertension: theoretical considerations.

Engel PJ, Baughman RP.

Med Hypotheses. 2009 Sep;73(3):448-52. doi: 10.1016/j.mehy.2009.03.029. Epub 2009 May 26.

PMID:
19473774

Supplemental Content

Loading ...
Support Center